These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2072670)

  • 1. Laryngeal electromyographic activity in adductor and abductor spasmodic dysphonia.
    Watson BC; Schaefer SD; Freeman FJ; Dembowski J; Kondraske G; Roark R
    J Speech Hear Res; 1991 Jun; 34(3):473-82. PubMed ID: 2072670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
    Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal muscle activity during speech breaks in adductor spasmodic dysphonia.
    Nash EA; Ludlow CL
    Laryngoscope; 1996 Apr; 106(4):484-9. PubMed ID: 8614226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal long latency response conditioning in abductor spasmodic dysphonia.
    Deleyiannis FW; Gillespie M; Bielamowicz S; Yamashita T; Ludlow CL
    Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):612-9. PubMed ID: 10378532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Listening: the key to diagnosing spasmodic dysphonia.
    Braden MN; Hapner ER
    ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia.
    Van Pelt F; Ludlow CL; Smith PJ
    Ann Otol Rhinol Laryngol; 1994 Mar; 103(3):192-200. PubMed ID: 8122835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
    Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
    J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analyses of electromyographic activity in spasmodic dysphonic and normal control subjects.
    Watson BC; McIntire D; Roark RM; Schaefer SD
    J Voice; 1995 Mar; 9(1):3-15. PubMed ID: 7757148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic variations in adductor spasmodic dysphonia as a function of speech task.
    Sapienza CM; Walton S; Murry T
    J Speech Lang Hear Res; 1999 Feb; 42(1):127-40. PubMed ID: 10025549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in adductor spasmodic dysphonia: acoustic evidence.
    Sapienza CM; Murry T; Brown WS
    J Voice; 1998 Jun; 12(2):214-22. PubMed ID: 9649077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior cricoarytenoid myoplasty with medialization thyroplasty in the management of refractory abductor spasmodic dysphonia.
    Shaw GY; Sechtem PR; Rideout B
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):303-6. PubMed ID: 12731624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electromyographic study of psychogenic dysphonias].
    Canals Ruiz P; Villoslada Prieto C; Marco Peiró A; López Catalá F; Peris Beaufils JL
    Acta Otorrinolaringol Esp; 1998; 49(5):400-3. PubMed ID: 9717331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
    Rodriquez AA; Ford CN; Bless DM; Harmon RL
    Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
    Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
    Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency of voice produced by patients with adductor spasmodic dysphonia: a preliminary investigation.
    Cimino-Knight AM; Sapienza CM
    J Speech Lang Hear Res; 2001 Aug; 44(4):793-802. PubMed ID: 11521772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal phonatory characteristics after botulinum toxin type A injection.
    Fisher KV; Scherer RC; Guo CG; Owen AS
    J Speech Hear Res; 1996 Oct; 39(5):968-80. PubMed ID: 8898251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
    Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; Mårtensson A
    J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia.
    Guiry S; Worthley A; Simonyan K
    Laryngoscope; 2019 Jul; 129(7):1627-1633. PubMed ID: 30582159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.